Forbidden Data: COVID-19 Vaccines, Cancer, and the Cost of Medical Censorship

“We don’t want to change. Every change is a menace to stability. That’s another reason why we’re so chary of applying new inventions. Every discovery in pure science is potentially subversive; even science must sometimes be treated as a possible enemy.” —Aldous Huxley, Brave New World

A recent study linking COVID-19 vaccinations to reports of new or rapidly worsening cancers has ignited controversy – not only because of what it describes, but because access to the research briefly disappeared after an apparent cyberattack on the hosting medical journal’s website. While the study itself stops short of claiming definitive proof, it documents hundreds of cancer cases linked to COVID-19 vaccination across multiple countries. Taken together with years of official assurances about vaccine safety and the aggressive silencing of dissenting scientific voices, the episode exposes a growing problem: the prevalence of medical censorship in an era when corporate profits are prioritized over transparency.

The study at the center of the storm was published in early January 2026 in the peer-reviewed journal Oncotarget. Written by cancer researchers from the United States, it reviews 69 previously published medical papers and case reports from around the world. The authors identify 333 cases in which cancer was either newly diagnosed or dramatically worsened within weeks of COVID-19 vaccination. Significantly, the patients come from 27 different countries and the studies cover a five-year period – thus making it difficult to dismiss the cases as isolated flukes.

Notably, therefore, within days of the study being published, the Oncotarget website went offline. This followed a similar incident occurring on the same site the previous month. The journal blamed a cyberattack and said it would be reported to the United States Federal Bureau of Investigation (FBI). Commenting on the attack, one of the study authors, Wafik S. El-Deiry, MD, openly stated on X that:

“The future is bleak if weaponized censorship in medicine continues to suppress any narratives that stand up to pharma.”

The only mainstream/legacy media website to report on the attack was the UK’s Daily Mail.

Whether the outage was sabotage, coincidence, or poor cybersecurity, the effect was the same: a sensitive piece of research became suddenly hard to find. In an era when authorities repeatedly insist that they “follow the science,” science becoming inaccessible is the worst possible look.

Asking Uncomfortable Questions

What did the study authors actually find? Importantly, they did not conduct a new experiment. Instead, they simply reviewed what had already been publicly reported in the medical literature since 2020. Most of the papers were individual case reports where doctors describe what they have observed in specific patients. Others were much larger population studies, including one involving around 300,000 people in Italy, another covering 8.4 million people in South Korea, and a U.S. analysis of 1.3 million military service members.

Across these reports, several worrying themes emerged. Some patients developed aggressive cancers shortly after vaccination. Others saw previously slow-growing or stable cancers suddenly accelerate. In a number of cases, unusual tumor activity was found close to the vaccine injection site or nearby lymph nodes. There were also reports suggesting that vaccination may have reactivated dormant viruses known to be linked with cancer, such as the virus responsible for Kaposi’s sarcoma – a cancer that causes dark lesions on the skin, mouth, or internal organs, and a weakened immune system.

The larger population studies added to the unease. In Italy and South Korea, vaccinated groups showed higher rates of certain cancers, including thyroid, breast, lung, colon, and prostate tumors. In some analyses, people who received more doses or boosters later on showed higher rates of some cancers than those receiving fewer.

Read More – Forbidden Data: COVID-19 Vaccines, Cancer, and the Cost of Medical Censorship